xenograft

You have access
Efficacy of Liposomal Curcumin in a Human Pancreatic Tumor Xenograft Model: Inhibition of Tumor Growth and Angiogenesis
AMALENDU P. RANJAN, ANINDITA MUKERJEE, LAWRENCE HELSON, ROHAN GUPTA and JAMBOOR K. VISHWANATHA

Anticancer Research September 2013, 33 (9) 3603-3609;
You have access
Antitumor Activity of Elacytarabine Combined with Bevacizumab, Cetuximab and Trastuzumab in Human NSCLC Xenografts
SKJALG BRUHEIM, MARIT LILAND SANDVOLD, GUNHILD M. MÆLANDSMO and ØYSTEIN FODSTAD

Anticancer Research September 2013, 33 (9) 3615-3621;
You have access
The Nanoparticulate Quillaja Saponin BBE Is Selectively Active Towards Renal Cell Carcinoma
SAADIA B. HASSAN, JOACHIM GULLBO, KEFEI HU, SAIDEH BERENJIAN, BROR MOREIN and PETER NYGREN

Anticancer Research January 2013, 33 (1) 143-151;
You have access
Establishment and Characterization of a Novel Xenograft Model of Human Gastrointestinal Stromal Tumor in Mice
MAKOTO MORIYAMA, YUTAKA SHIMADA, TAKUYA NAGATA, TETSUYA OMURA, SHINICHI SEKINE, KOSHI MATSUI, ISAKU YOSHIOKA, TOMOYUKI OKUMURA, SHIGEAKI SAWADA, TORU YOSHIDA and KAZUHIRO TSUKADA

Anticancer Research January 2013, 33 (1) 175-181;
You have access
Effects of Voltage-gated K⁺ Channel Blockers in Gefitinib-resistant H460 Non-small Cell Lung Cancer Cells
WON IL JEON, PAN DONG RYU and SO YEONG LEE

Anticancer Research December 2012, 32 (12) 5279-5284;

Main menu